Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,997	906.14	1,903	3,992	15,997	16,718
Short-Term Investments	-	-	-	11,269	1,200	13,032
Cash & Short-Term Investments	3,997	906.14	1,903	15,261	17,197	29,750
Cash Growth	-58.37%	-52.40%	-87.53%	-11.26%	-42.19%	170.72%
Accounts Receivable	35,406	35,813	34,181	31,012	30,137	25,746
Other Receivables	71.12	86.62	123.85	120.23	57.85	526.21
Receivables	35,477	35,900	34,304	31,133	30,195	26,272
Inventory	34,728	32,511	24,742	24,177	24,084	22,413
Prepaid Expenses	11,246	-	-	-	767.79	330.34
Other Current Assets	2,017	11,797	13,832	6,140	279.56	434.11
Total Current Assets	87,464	81,115	74,781	76,711	72,523	79,200
Property, Plant & Equipment	249,690	242,198	233,946	103,394	64,808	71,902
Long-Term Investments	803.04	797.39	782.42	838.64	1,066	1,025
Other Intangible Assets	1,797	1,917	3,136	1,295	1,726	1,731
Long-Term Accounts Receivable	-0	0	0	0	0	0
Long-Term Deferred Tax Assets	-	-	-	-	1,927	-
Long-Term Deferred Charges	828.66	902.04	-	-	-	-
Other Long-Term Assets	43,645	43,750	44,054	44,167	49,610	30,017
Total Assets	384,228	370,680	356,700	226,405	191,661	183,875
Accounts Payable	18,386	21,004	13,660	8,541	10,826	9,130
Accrued Expenses	4,409	3,282	4,013	11,153	3,842	2,828
Short-Term Debt	50,647	73,490	80,562	75,733	57,356	47,545
Current Portion of Long-Term Debt	25,230	51,208	4,940	16,560	16,416	500.4
Current Portion of Leases	578.25	387.37	452.59	308.27	323.43	306.54
Current Income Taxes Payable	1,562	2,417	1,949	-	1,686	74.92
Current Unearned Revenue	179.98	112.34	179.99	171.28	171.02	169.8
Other Current Liabilities	15,095	16,774	26,836	9,208	8,064	7,601
Total Current Liabilities	116,087	168,675	132,592	121,674	98,684	68,156
Long-Term Debt	67,643	49,568	71,918	31,911	20,000	44,994
Long-Term Leases	1,227	1,225	1,387	1,003	306.55	285.97
Long-Term Unearned Revenue	13.62	36.38	66.15	222.65	385.44	547.83
Long-Term Deferred Tax Liabilities	8,370	9,752	13,172	-	-	-
Other Long-Term Liabilities	2,155	2,286	5,120	4,202	4,139	4,045
Total Liabilities	209,582	242,853	230,881	160,658	128,110	121,602
Common Stock	10,799	7,613	6,857	6,769	6,695	6,500
Additional Paid-In Capital	87,370	44,008	40,481	35,248	26,752	23,164
Retained Earnings	25,809	28,019	26,605	27,741	35,034	35,216
Treasury Stock	-2,517	-4,161	-4,142	-5,431	-3,765	-2,420
Comprehensive Income & Other	53,186	52,349	56,019	1,420	-1,164	-187.38
Shareholders' Equity	174,646	127,827	125,820	65,746	63,551	62,272
Total Liabilities & Equity	384,228	370,680	356,700	226,405	191,661	183,875
Total Debt	145,324	175,879	159,258	125,515	94,403	93,632
Net Cash (Debt)	-141,328	-174,973	-157,355	-110,254	-77,205	-63,882
Net Cash Per Share	-8452.30	-12135.18	-11286.13	-7972.68	-5741.73	-4756.82
Filing Date Shares Outstanding	21.14	14.46	14.25	13.77	13.77	13.48
Total Common Shares Outstanding	21.14	14.46	14.25	13.77	13.77	13.48
Working Capital	-28,623	-87,560	-57,811	-44,964	-26,160	11,044
Book Value Per Share	8263.35	8838.31	8830.45	4776.06	4616.27	4620.60
Tangible Book Value	172,849	125,911	122,683	64,451	61,825	60,541
Tangible Book Value Per Share	8178.30	8705.79	8610.32	4681.97	4490.90	4492.15
Land	64,487	64,487	67,149	2,501	2,578	14,492
Buildings	48,153	47,136	47,154	46,000	43,986	51,935
Machinery	44,175	44,846	43,178	44,758	42,591	39,143
Construction In Progress	140,961	132,199	120,009	55,341	22,792	12,050

Source: S&P Capital IQ. Standard template. Financial Sources.